You are here : Home > BCI Laboratory > New pharmacological target for the treatment of Cushing's syndrome associated with macronodular adrenocortical hyperplasia

highlight / actuality

New pharmacological target for the treatment of Cushing's syndrome associated with macronodular adrenocortical hyperplasia



Work carried out by researchers within our laboratory identified a new molecular target for pharmacological pharmacological control of adrenal Cushing’s syndrome which is an interesting alternative to adrenalectomy.​​

Published on 15 November 2010
Highlight available in French.

Top page